Proper Storage of ENBREL
ENBREL must always be kept cool—at 36°F to 46°F (2°C to 8°C; the standard temperature range of most refrigerators)—until you are ready to use it.
- Do NOT freeze ENBREL
- Keep ENBREL in the original carton and protected from light
- Do NOT shake
- Keep ENBREL and all medicines out of the reach of children
- Contact ENBREL Support™ to receive an ENBREL travel pack at no cost so you can easily take ENBREL with you. Call 1-888-4ENBREL (1-888-436-2735).
- You can carry ENBREL with you, wrapped in bubble wrap, placed in the travel cooler provided by ENBREL Support™, and packed with an ice refrigerant. Put a thermometer in the cooler and check it every few hours, adding ice as necessary to maintain a 36°F to 46°F (2°C to 8°C) temperature.
- Before traveling, check with your airline about the carry-on policy regarding syringes. Currently, you may carry needles and syringes on the airplane, provided you can show a medical need for them. For this reason, you may also wish to carry medical documentation to present to airport security. Notify security if you are carrying a sharps disposal container in your carry-on baggage.
- Make sure that your ENBREL is clearly labeled. Try to use the original carton with its original labels.
Be sure to stick to your regular treatment schedule, even when you are traveling.
Please see Prescribing Information, Important Safety Information, and Medication Guide for complete details about ENBREL.
Prescription ENBREL is taken by injection.
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.
ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.
ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.